Suppr超能文献

发现新型苯并吡喃酮衍生物作为强效和选择性的 MCH1R 拮抗剂。

Discovery of novel phenylpyridone derivatives as potent and selective MCH1R antagonists.

机构信息

Tsukuba Research Institute, Banyu Pharmaceutical Co. Ltd, Japan.

出版信息

Bioorg Med Chem. 2011 Jan 15;19(2):883-93. doi: 10.1016/j.bmc.2010.12.002. Epub 2010 Dec 6.

Abstract

The design, synthesis and structure-activity relationships of a novel class of N-phenylpyridone MCH1R antagonists are described. The core part of the N-phenylpyridone structure was newly designed and the side chain moieties that were attached to the core part were extensively explored. As a result of optimization of the N-phenylpyridone leads, we successfully developed the orally available, and brain-penetrable MCH1R selective antagonist 7c, exhibiting excellent anti-obese effect in diet-induced obese (DIO) mice.

摘要

本文描述了一类新型 N-苯基吡啶酮 MCH1R 拮抗剂的设计、合成及构效关系。新设计了 N-苯基吡啶酮结构的核心部分,并广泛探索了连接到核心部分的侧链部分。通过对 N-苯基吡啶酮先导化合物的优化,我们成功开发出了可口服、可穿透血脑屏障的 MCH1R 选择性拮抗剂 7c,在饮食诱导肥胖(DIO)小鼠中表现出优异的抗肥胖效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验